Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Vertex Pharmaceuticals (NQ: VRTX ) 455.31 +1.76 (+0.39%) Streaming Delayed Price Updated: 4:00 PM EDT, Oct 4, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Vertex Pharmaceuticals < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > These 2 Incredible Growth Stocks Are Set to Soar This Summer and Beyond August 18, 2024 It's always a good time to invest cash in quality businesses. Via The Motley Fool 3 Fantastic Growth Stocks to Buy in August August 17, 2024 These stocks should keep up their winning ways. Via The Motley Fool 10 Health Care Stocks With Whale Alerts In Today's Session August 15, 2024 Via Benzinga 3 Biotech Stocks to Buy on the Dip: August 2024 August 15, 2024 These are three of the best biotech stocks to buy on the dip due to their strong fundamentals and market positioning. Via InvestorPlace Prediction: These 4 Future Technologies Will Be Millionaire-Makers -- and Here Are the Top Stocks to Buy Now to Profit From Them August 15, 2024 These technologies could be game-changers. And they could make forward-thinking investors a lot of money. Via The Motley Fool Unpacking the Latest Options Trading Trends in Vertex Pharmaceuticals August 09, 2024 Via Benzinga Vertex Slumps On Light Second-Quarter Despite Hiked 2024 Outlook August 01, 2024 The company's sales came in a hair light with losses wider than expected. Via Investor's Business Daily 14 Analysts Assess Vertex Pharmaceuticals: What You Need To Know July 31, 2024 Via Benzinga 2 Biotech Stocks to Buy Hand Over Fist in August August 12, 2024 Both of these biotechs are highly innovative companies. Via The Motley Fool The 3 Best Biotech Stocks to Buy in August 2024 August 08, 2024 These biotech stocks are leading the way with groundbreaking therapies and robust fundamentals offering superb upside ahead. Via InvestorPlace Vertex Announces CASGEVY™ Reimbursement Agreement for the Treatment of Transfusion-Dependent Beta Thalassemia in England August 07, 2024 From Vertex Pharmaceuticals Via Business Wire Is It Too Late to Buy Vertex Pharmaceuticals Stock? August 06, 2024 Shares of the rare disease drugmaker are already up more than 40% over the past year. Via The Motley Fool Prediction: These Could Be the Best-Performing Growth Stocks Through 2030 August 05, 2024 Great companies are found in every type of market landscape. Via The Motley Fool 3 Biotech Stocks on Track for 50% Returns (or More) by 2028 August 04, 2024 Investors should consider snapping up these high potential biotech stocks that could return 50% or more by 2028! Via InvestorPlace Prediction: CRISPR Therapeutics Stock Could Be a Millionaire-Maker August 04, 2024 The biotech recently became a commercial-stage company. Via The Motley Fool 3 Unstoppable Stocks to Buy in August August 03, 2024 It's not hard to envision how all three of these stocks can deliver exceptional growth. Via The Motley Fool Prediction: 2 Stocks That Will Be Worth More Than Johnson & Johnson 10 Years From Now August 03, 2024 These two healthcare companies have far more upside potential than Johnson & Johnson. Via The Motley Fool 3 Biotech Stocks That Could Have Investors Grinning Soon August 02, 2024 Biotech stocks are a high risk, high reward investment and these three biotechs offer significant upside potential. Via InvestorPlace Magnificent 7 Lose Over $300B As Volatility Index Surges, Traders Question Fed's Timing: What's Driving Markets Friday? August 02, 2024 Wall Street is experiencing a sharp decline on the last trading day of the week, with all indices in the red at noon in New York, as a cooler-than-expected July jobs report rattled risk sentiment and... Via Benzinga Topics Economy Exposures Interest Rates Vertex Pharmaceuticals Lifts Annual Guidance, Positive Growth For Its Cystic Fibrosis Franchise And Pain Management Pipeline August 02, 2024 Vertex Pharmaceuticals reported Q2 revenues of $2.65B, near the $2.66B estimate, with an adjusted EPS loss of $(12.83), missing the $4.14 consensus. The analyst expects strong growth in the pain... Via Benzinga Should Investors Worry About Vertex Pharmaceuticals $3.6 Billion Q2 Loss? Not Even for a Second. August 02, 2024 Vertex's first loss in years is a big nothingburger. Via The Motley Fool Vertex Pharmaceuticals (VRTX) Q2 2024 Earnings Call Transcript August 01, 2024 VRTX earnings call for the period ending June 30, 2024. Via The Motley Fool Topics Earnings Exposures Financial Vertex Reports Second Quarter 2024 Financial Results August 01, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire US Stocks Tumble On Economic, Geopolitical Concerns; Small Caps, Chipmakers Sink; Meta Rallies: What's Driving Markets Thursday? August 01, 2024 Markets experienced a sharp downturn, driven by heightened geopolitical tensions and economic uncertainties that negatively impacted investor risk sentiment, just a day after the Federal Open Market... Via Benzinga Got $500? 2 Compelling Growth Stocks to Buy and Hold Forever August 01, 2024 These businesses are looking like increasingly attractive buys. Via The Motley Fool Wall Street Looks To Ride On Earnings Cheer As Meta Q2 Impresses Investors: Analyst Says Economic Data, Stock Performances Suggest Republican Win In November August 01, 2024 After Wednesday’s tech-led rebound amid the Federal Reserve’s rate decision, the stock market could be in for further gains. The major index futures point to a higher opening, although suggesting a... Via Benzinga The Top 3 Biotech Stocks to Buy Now Summer 2024 July 31, 2024 These biotech stocks are well-positioned to generate high returns for investors due to their significant growth prospects. Via InvestorPlace Vertex Announces FDA Acceptance of New Drug Application for Suzetrigine for the Treatment of Moderate-to-Severe Acute Pain July 30, 2024 From Vertex Pharmaceuticals Incorporated Via Business Wire DexCom Stock Plunged Over 40% Last Week. Are Eli Lilly's and Novo Nordisk's Drugs to Blame? July 30, 2024 DexCom faces several challenges, but GLP-1 drugs aren't big problems for the company right now. Via The Motley Fool The Top 3 Cathie Wood Stocks to Buy Now: Summer 2024 July 29, 2024 The investing guru likes to take the pulse of where the world will be tomorrow and these Cathie Wood stocks reflect that vision. Via InvestorPlace < Previous 1 2 3 4 5 6 7 8 9 ... 52 53 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.